Index RUT P/E - EPS (ttm) -0.81 Insider Own 53.41% Shs Outstand 188.95M Perf Week 5.86%
Market Cap 2.18B Forward P/E - EPS next Y -0.50 Insider Trans -0.91% Shs Float 89.14M Perf Month 32.48%
Income -152.79M PEG - EPS next Q -0.14 Inst Own 41.06% Short Float 5.03% Perf Quarter 50.73%
Sales 2.23B P/S 0.98 EPS this Y 14.78% Inst Trans -2.45% Short Ratio 4.46 Perf Half Y 130.36%
Book/sh 0.65 P/B 17.59 EPS next Y 25.95% ROA -20.37% Short Interest 4.48M Perf Year 82.08%
Cash/sh - P/C - EPS next 5Y - ROE -91.58% 52W Range 4.46 - 12.36 Perf YTD 32.17%
Dividend Est. 1.24 (10.87% ) P/FCF - EPS past 5Y -35.06% ROI -44.46% 52W High -7.93% Beta 1.39
Dividend TTM - Quick Ratio - Sales past 5Y 24.61% Gross Margin - 52W Low 155.16% ATR (14) 0.66
Dividend Ex-Date - Current Ratio 1.61 EPS Y/Y TTM 8.96% Oper. Margin -5.88% RSI (14) 65.79 Volatility 6.57% 6.73%
Employees 1536 Debt/Eq 1.78 Sales Y/Y TTM 37.46% Profit Margin -6.85% Recom 1.92 Target Price 10.14
Option/Short Yes / Yes LT Debt/Eq 1.78 EPS Q/Q 17.83% Payout - Rel Volume 2.51 Prev Close 11.68
Sales Surprise 6.84% EPS Surprise 8.90% Sales Q/Q 47.34% Earnings Aug 01 AMC Avg Volume 1.01M Price 11.38
SMA20 16.34% SMA50 22.71% SMA200 54.12% Trades
Volume 2,442,495 Change -2.57%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-24 Upgrade BofA Securities
Neutral → Buy
$7.75 → $11
May-30-24 Initiated Robert W. Baird
Outperform
$10
May-08-24 Upgrade Piper Sandler
Neutral → Overweight
$6 → $8
Mar-06-24 Initiated Barclays
Underweight
$4.50
Mar-06-24 Downgrade Piper Sandler
Overweight → Neutral
$12 → $6
Jan-24-24 Initiated Stifel
Buy
$11
Nov-02-23 Downgrade BofA Securities
Buy → Neutral
$7.50 → $7.25
Oct-16-23 Upgrade Raymond James
Outperform → Strong Buy
$9 → $10
Oct-12-23 Initiated Stephens
Equal-Weight
$9
May-01-23 Upgrade Raymond James
Mkt Perform → Outperform
$9
Feb-23-23 Downgrade JP Morgan
Overweight → Neutral
$22 → $12
Nov-21-22 Downgrade Raymond James
Outperform → Mkt Perform
Sep-08-22 Resumed Piper Sandler
Overweight
$19
May-26-22 Upgrade BofA Securities
Neutral → Buy
$18 → $14
Dec-14-21 Initiated Goldman
Buy
$20
Dec-03-21 Initiated JP Morgan
Overweight
$20
Sep-10-21 Initiated Cowen
Outperform
$24
Aug-12-21 Initiated Barclays
Overweight
$25
Apr-20-21 Initiated William Blair
Outperform
Apr-20-21 Initiated UBS
Neutral
$28
Show Previous Ratings
Sep-09-24 03:27PM
Sep-05-24 08:00AM
Aug-29-24 08:00AM
Aug-28-24 08:00AM
Aug-21-24 08:00AM
07:03PM
Loading…
Aug-16-24 07:03PM
04:30PM
Aug-01-24 07:30PM
05:35PM
04:35PM
(Associated Press Finance)
04:01PM
Jul-30-24 08:00AM
Jul-20-24 01:07AM
01:06AM
Jul-18-24 07:01PM
07:01PM
Loading…
Jul-16-24 07:01PM
Jul-12-24 08:10AM
Jul-11-24 08:00AM
Jun-24-24 08:00AM
Jun-18-24 02:11AM
Jun-15-24 02:53AM
May-22-24 08:00AM
May-08-24 07:09AM
May-04-24 10:52AM
May-03-24 11:30AM
08:21AM
(Thomson Reuters StreetEvents)
May-02-24 08:59PM
07:00PM
05:55PM
05:35PM
04:32PM
Loading…
04:32PM
(Associated Press Finance)
04:01PM
Apr-30-24 08:00AM
Apr-25-24 10:01AM
Apr-11-24 08:00AM
Apr-02-24 08:00AM
Mar-21-24 07:02PM
07:01PM
Mar-16-24 01:49AM
Mar-07-24 04:30PM
Feb-29-24 05:38PM
(GlobeNewswire) +6.01%
-6.00%
Feb-28-24 09:32AM
08:19AM
(Thomson Reuters StreetEvents)
Feb-27-24 06:30PM
04:59PM
(Associated Press Finance)
04:46PM
04:01PM
Feb-26-24 09:15AM
Feb-20-24 10:00AM
Feb-06-24 08:00AM
Jan-09-24 08:00AM
07:39AM
Jan-08-24 08:00AM
Dec-19-23 08:00AM
Dec-01-23 08:00AM
Nov-29-23 09:43AM
Nov-05-23 03:02PM
Nov-02-23 07:00PM
06:57PM
04:26PM
(Associated Press Finance)
04:01PM
Oct-25-23 08:00AM
Oct-20-23 05:47PM
Oct-17-23 08:00AM
07:16AM
Oct-16-23 08:00AM
Oct-12-23 08:00AM
Oct-10-23 01:57PM
11:00AM
Oct-03-23 08:00AM
Oct-02-23 08:00AM
Sep-18-23 08:52AM
Sep-15-23 07:00PM
Sep-07-23 06:00AM
Sep-06-23 04:01PM
Aug-30-23 08:00AM
Aug-03-23 10:30PM
05:25PM
04:14PM
04:01PM
Jul-31-23 08:00AM
Jul-20-23 11:35AM
Jul-18-23 08:00AM
Jul-17-23 04:05PM
Jul-13-23 08:00AM
Jul-10-23 08:44AM
Jul-09-23 09:44AM
Jul-06-23 08:00AM
Jul-05-23 11:00AM
Jun-21-23 09:58AM
Jun-06-23 08:00AM
May-24-23 08:00AM
May-04-23 06:25PM
05:21PM
04:01PM
Apr-26-23 08:00AM
Apr-25-23 11:00AM
Apr-18-23 10:40AM
Apr-14-23 08:00AM
Apr-04-23 09:04AM
Alignment Healthcare, Inc. operates as a holding company. The company offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The firm offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered Orange, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Maroney Dawn Christine President, Markets Sep 16 '24 Sale 11.70 30,000 351,027 1,756,097 Sep 18 04:20 PM KONOWIECKI JOSEPH S Director Sep 17 '24 Sale 11.77 16,413 193,181 1,141,808 Sep 18 04:18 PM KAO JOHN E Chief Executive Officer Sep 16 '24 Sale 11.70 90,000 1,052,874 2,633,100 Sep 18 04:16 PM Joseph Konowiecki Director Sep 17 '24 Proposed Sale 11.89 15,690 186,554 Sep 16 07:04 PM DAWN MARONEY Officer Sep 16 '24 Proposed Sale 11.89 90,000 1,070,100 Sep 16 04:40 PM JEK TRUST U/A DTD 02/08/2021 Director Sep 16 '24 Proposed Sale 11.89 360,000 4,280,400 Sep 16 04:33 PM Kardes Hakan Chief Experience Officer Sep 12 '24 Sale 11.48 25,000 287,052 380,444 Sep 13 06:24 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Sep 11 '24 Sale 9.61 34,626 332,925 365,112 Sep 13 06:22 PM KONOWIECKI JOSEPH S Director Sep 13 '24 Sale 12.00 25,000 300,012 1,158,221 Sep 13 06:21 PM KONOWIECKI JOSEPH S Director Sep 12 '24 Sale 11.00 25,000 275,092 1,183,221 Sep 13 06:21 PM Freeman Robert Thomas Chief Financial Officer Sep 12 '24 Sale 11.00 120,500 1,326,054 278,929 Sep 13 06:19 PM Freeman Robert Thomas Chief Financial Officer Sep 13 '24 Sale 12.00 14,500 174,013 264,429 Sep 13 06:19 PM Freeman Robert Thomas Chief Financial Officer Sep 11 '24 Sale 10.01 8,561 85,688 399,429 Sep 13 06:19 PM MARGOLIS FAMILY TRUST U/A DTD1 Officer Sep 13 '24 Proposed Sale 11.58 4,200 48,636 Sep 13 04:23 PM KONOWIECKI JOSEPH S Director Sep 13 '24 Proposed Sale 11.95 25,000 298,748 Sep 13 01:20 PM HAKAN KARDES Officer Sep 12 '24 Proposed Sale 10.75 25,000 268,750 Sep 12 04:28 PM FCO HOLDINGS LLC Officer Sep 12 '24 Proposed Sale 10.75 137,000 1,472,750 Sep 12 04:28 PM KONOWIECKI JOSEPH S Director Sep 12 '24 Proposed Sale 10.95 25,000 273,834 Sep 12 03:54 PM Christopher Joyce Officer Sep 11 '24 Proposed Sale 9.45 24,467 231,213 Sep 11 09:46 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Sep 05 '24 Sale 10.00 4,541 45,422 399,738 Sep 06 05:29 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Sep 04 '24 Sale 10.00 1,300 13,000 404,279 Sep 06 05:29 PM Freeman Robert Thomas Chief Financial Officer Sep 05 '24 Sale 10.00 4,789 47,913 407,990 Sep 06 05:28 PM Freeman Robert Thomas Chief Financial Officer Sep 04 '24 Sale 10.00 1,650 16,500 412,779 Sep 06 05:28 PM CHRISTOPHER J. JOYCE Officer Sep 04 '24 Proposed Sale 9.81 16,667 163,503 Sep 04 04:18 PM Maroney Dawn Christine President, Markets Aug 22 '24 Sale 9.02 7,074 63,780 1,789,023 Aug 23 05:27 PM Maroney Dawn Christine President, Markets Aug 23 '24 Sale 9.06 2,926 26,510 1,786,097 Aug 23 05:27 PM Maroney Dawn Christine President, Markets Aug 15 '24 Sale 8.70 20,000 174,020 1,796,097 Aug 16 04:51 PM MARGOLIS JEFFREY H Director Aug 14 '24 Sale 8.83 1,200 10,596 413,533 Aug 16 04:47 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Aug 02 '24 Sale 9.00 1,333 11,998 405,579 Aug 06 06:13 PM KONOWIECKI JOSEPH S Director Jul 17 '24 Sale 10.00 25,000 250,001 1,208,221 Jul 19 08:27 PM Maroney Dawn Christine President, Markets Jul 18 '24 Sale 10.00 40,137 401,378 1,852,797 Jul 19 08:24 PM Maroney Dawn Christine President, Markets Jul 19 '24 Sale 10.01 36,700 367,209 1,816,097 Jul 19 08:24 PM Maroney Dawn Christine President, Markets Jul 17 '24 Sale 10.00 23,163 231,642 1,892,934 Jul 19 08:24 PM Freeman Robert Thomas Chief Financial Officer Jul 18 '24 Sale 10.00 44,042 440,433 453,287 Jul 19 08:22 PM Freeman Robert Thomas Chief Financial Officer Jul 19 '24 Sale 10.01 38,858 388,790 414,429 Jul 19 08:22 PM Freeman Robert Thomas Chief Financial Officer Jul 17 '24 Sale 10.00 22,100 221,013 497,329 Jul 19 08:22 PM Kardes Hakan Chief Experience Officer Jul 16 '24 Sale 9.98 25,000 249,500 405,444 Jul 18 04:41 PM KONOWIECKI JOSEPH S Chairman of the Board Jul 15 '24 Sale 9.06 22,400 203,036 1,233,221 Jul 16 08:29 PM KONOWIECKI JOSEPH S Chairman of the Board Jul 12 '24 Sale 9.00 2,600 23,403 1,255,621 Jul 16 08:29 PM MARGOLIS JEFFREY H Director Jul 15 '24 Sale 8.94 1,200 10,728 414,733 Jul 16 04:33 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jul 15 '24 Sale 9.05 15,034 136,032 406,912 Jul 16 04:30 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jul 12 '24 Sale 9.00 300 2,700 421,946 Jul 16 04:30 PM Maroney Dawn Christine President, Markets Jul 15 '24 Sale 9.04 39,700 358,690 1,916,097 Jul 16 04:29 PM Maroney Dawn Christine President, Markets Jul 12 '24 Sale 9.00 300 2,700 1,955,797 Jul 16 04:29 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jul 01 '24 Sale 8.00 666 5,328 422,246 Jul 03 05:37 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jun 14 '24 Sale 8.01 16,000 128,198 422,912 Jun 17 08:29 PM MARGOLIS JEFFREY H Director Jun 14 '24 Sale 8.06 1,200 9,672 415,933 Jun 17 08:28 PM Maroney Dawn Christine President, Markets Jun 12 '24 Sale 8.21 20,000 164,200 1,956,097 Jun 14 05:49 PM Scavo Robert L. Chief Information Officer Mar 28 '24 Sale 4.84 1,821 8,814 436,822 Mar 29 08:00 PM Maroney Dawn Christine President, Markets Mar 28 '24 Sale 4.84 10,151 49,131 1,976,097 Mar 29 08:00 PM Freeman Robert Thomas Chief Financial Officer Mar 28 '24 Sale 4.84 4,299 20,807 865,407 Mar 29 08:00 PM Kardes Hakan Chief Experience Officer Mar 28 '24 Sale 4.84 4,363 21,117 430,444 Mar 29 08:00 PM Maroney Dawn Christine President, Markets Mar 19 '24 Sale 5.05 15,861 80,111 1,999,500 Mar 21 05:00 PM Maroney Dawn Christine President, Markets Mar 20 '24 Sale 4.83 13,252 64,007 1,986,248 Mar 21 05:00 PM Scavo Robert L. Chief Information Officer Mar 19 '24 Sale 5.05 3,078 15,546 438,643 Mar 21 05:00 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Mar 19 '24 Sale 5.05 25,060 126,573 438,912 Mar 21 05:00 PM Kim Hyong Chief Medical Officer Mar 19 '24 Sale 5.05 5,576 28,163 555,530 Mar 21 05:00 PM Kardes Hakan Chief Experience Officer Mar 19 '24 Sale 5.05 18,964 95,783 434,807 Mar 21 05:00 PM Freeman Robert Thomas Chief Financial Officer Mar 19 '24 Sale 5.05 28,522 144,059 869,706 Mar 21 05:00 PM KAO JOHN E Chief Executive Officer Mar 14 '24 Buy 4.82 103,000 496,779 2,745,253 Mar 18 05:27 PM Scavo Robert L. Chief Information Officer Mar 15 '24 Sale 4.89 4,852 23,732 441,721 Mar 15 08:00 PM Maroney Dawn Christine President, Markets Mar 15 '24 Sale 4.89 21,537 105,340 2,015,361 Mar 15 08:00 PM Freeman Robert Thomas Chief Financial Officer Mar 15 '24 Sale 4.89 11,858 57,999 898,228 Mar 15 08:00 PM Kardes Hakan Chief Experience Officer Mar 15 '24 Sale 4.89 4,326 21,159 453,771 Mar 15 08:00 PM Maroney Dawn Christine President, Markets Mar 08 '24 Sale 5.44 23,000 125,076 1,830,008 Mar 12 06:00 PM MARGOLIS JEFFREY H Director Dec 14 '23 Sale 8.46 1,200 10,152 417,133 Dec 15 05:00 PM MARGOLIS JEFFREY H Director Dec 06 '23 Sale 8.00 1,200 9,600 418,333 Dec 07 08:00 AM KONOWIECKI JOSEPH S Chairman of the Board Nov 10 '23 Sale 5.90 4,898 28,898 1,188,221 Nov 15 08:24 PM MARGOLIS JEFFREY H Director Oct 16 '23 Sale 8.00 6,000 48,016 419,533 Oct 18 05:00 PM
Index RUT P/E - EPS (ttm) -5.17 Insider Own 38.08% Shs Outstand 132.63M Perf Week 0.98%
Market Cap 1.52B Forward P/E 10.26 EPS next Y 1.10 Insider Trans -0.28% Shs Float 83.27M Perf Month 6.59%
Income -692.93M PEG - EPS next Q 0.19 Inst Own 60.33% Short Float 9.61% Perf Quarter 0.80%
Sales 3.26B P/S 0.47 EPS this Y -41.36% Inst Trans 10.34% Short Ratio 6.99 Perf Half Y 7.90%
Book/sh 11.48 P/B 0.99 EPS next Y 42.99% ROA -14.27% Short Interest 8.00M Perf Year 18.76%
Cash/sh 0.52 P/C 21.82 EPS next 5Y 14.00% ROE -37.80% 52W Range 6.37 - 11.90 Perf YTD 55.42%
Dividend Est. - P/FCF 9.17 EPS past 5Y - ROI -19.08% 52W High -4.79% Beta 1.09
Dividend TTM - Quick Ratio 0.94 Sales past 5Y 62.79% Gross Margin 14.28% 52W Low 77.86% ATR (14) 0.49
Dividend Ex-Date - Current Ratio 1.15 EPS Y/Y TTM -1863.13% Oper. Margin 8.45% RSI (14) 56.80 Volatility 4.15% 4.48%
Employees 10700 Debt/Eq 1.50 Sales Y/Y TTM 6.05% Profit Margin -21.25% Recom 1.78 Target Price 12.44
Option/Short Yes / Yes LT Debt/Eq 1.44 EPS Q/Q 39.19% Payout - Rel Volume 1.04 Prev Close 11.49
Sales Surprise 0.42% EPS Surprise 12.64% Sales Q/Q 1.60% Earnings Aug 06 BMO Avg Volume 1.14M Price 11.33
SMA20 4.07% SMA50 6.20% SMA200 18.89% Trades
Volume 1,202,134 Change -1.39%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-08-24 Downgrade Jefferies
Buy → Hold
$14.50 → $8
Nov-08-23 Downgrade BofA Securities
Neutral → Underperform
$9.50 → $6.50
May-10-23 Downgrade Stifel
Buy → Hold
$18 → $11
May-10-23 Downgrade Deutsche Bank
Buy → Hold
$28 → $11.30
May-09-23 Downgrade BofA Securities
Buy → Neutral
$21 → $12
Sep-27-21 Initiated SVB Leerink
Outperform
$30
Jul-14-21 Upgrade Robert W. Baird
Neutral → Outperform
$30 → $36
Apr-13-21 Downgrade Robert W. Baird
Outperform → Neutral
Mar-18-21 Initiated Truist
Buy
Jan-26-21 Initiated BofA Securities
Buy
$46
Dec-10-20 Initiated UBS
Buy
$49
Aug-10-20 Initiated Canaccord Genuity
Buy
$31
Jul-01-20 Resumed SVB Leerink
Outperform
$21
Jun-09-20 Initiated RBC Capital Mkts
Outperform
$24
Jan-31-20 Initiated Stifel
Buy
$17
Jan-07-20 Initiated Jefferies
Buy
$15
Dec-11-19 Initiated SVB Leerink
Outperform
Dec-10-19 Initiated Deutsche Bank
Buy
Show Previous Ratings
Sep-17-24 03:28PM
(Investor's Business Daily)
Sep-16-24 08:00AM
Aug-27-24 08:30AM
Aug-26-24 07:30AM
Aug-08-24 04:05PM
08:30AM
Loading…
Aug-06-24 08:30AM
07:00AM
Jul-16-24 08:30AM
Jul-12-24 09:13AM
Jul-02-24 05:21PM
May-22-24 04:39PM
04:36PM
04:33PM
04:30PM
May-20-24 04:05PM
04:45PM
Loading…
May-14-24 04:45PM
May-08-24 02:57PM
08:00AM
03:19AM
May-07-24 09:48AM
08:43AM
08:36AM
08:10AM
07:00AM
Apr-24-24 09:40AM
Apr-18-24 08:00AM
Apr-17-24 06:51PM
04:15PM
Apr-08-24 09:40AM
Mar-22-24 09:40AM
11:59AM
Loading…
Mar-08-24 11:59AM
Mar-06-24 09:40AM
Mar-04-24 04:05PM
Mar-01-24 08:00AM
Feb-28-24 10:53AM
Feb-27-24 10:53PM
(Thomson Reuters StreetEvents) +31.06%
11:28AM
07:33AM
07:00AM
Feb-08-24 04:05PM
Dec-19-23 05:05PM
Nov-10-23 08:00AM
Nov-08-23 05:11PM
Nov-07-23 11:41PM
(Thomson Reuters StreetEvents) -8.99%
08:11AM
07:00AM
Oct-17-23 04:05PM
Oct-11-23 12:07PM
Sep-20-23 12:47PM
(Associated Press Finance) -6.49%
11:44AM
08:54AM
08:45AM
08:38AM
Sep-14-23 07:37PM
01:31PM
Sep-07-23 08:00AM
Aug-17-23 07:17PM
07:31AM
Aug-08-23 10:50AM
06:30AM
Aug-03-23 08:00AM
Aug-02-23 01:24PM
Jul-18-23 08:00AM
Jul-17-23 07:27AM
Jun-28-23 08:12AM
Jun-27-23 08:16AM
Jun-21-23 08:00PM
Jun-20-23 08:40AM
May-19-23 08:32AM
May-15-23 12:28PM
May-11-23 02:00PM
May-09-23 06:18PM
08:55AM
07:35AM
07:35AM
Apr-26-23 08:00PM
Apr-18-23 08:32AM
Apr-17-23 09:10AM
Apr-11-23 04:15PM
Mar-27-23 08:22AM
Mar-02-23 05:44AM
Mar-01-23 05:08AM
01:01AM
(Thomson Reuters StreetEvents)
Feb-28-23 12:00PM
10:55AM
Feb-27-23 07:45PM
05:28PM
Feb-25-23 02:14PM
Feb-21-23 10:00AM
Feb-14-23 07:00AM
Feb-07-23 05:32AM
Jan-11-23 03:13PM
(Investor's Business Daily)
Jan-10-23 07:33PM
11:25AM
Dec-23-22 04:53PM
Dec-21-22 05:15AM
Nov-30-22 12:46PM
10:53AM
Nov-16-22 08:34AM
Nov-10-22 06:23AM
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Richard A. Barasch Former Affiliate Sep 18 '24 Proposed Sale 11.48 40,022 459,452 Sep 18 07:20 PM Richard A. Barasch Former Affiliate Sep 16 '24 Proposed Sale 11.13 14,970 166,616 Sep 16 06:38 PM Richard A. Barasch Former Affiliate Sep 12 '24 Proposed Sale 11.31 10,000 113,100 Sep 12 04:53 PM Prast Albert A. Chief Technology Officer Mar 04 '24 Option Exercise 2.69 135,443 364,342 316,526 Sep 05 06:45 PM Prast Albert A. Chief Technology Officer Mar 04 '24 Sale 10.41 135,443 1,409,962 181,083 Sep 05 06:45 PM Richard A. Barasch Former Affiliate Sep 05 '24 Proposed Sale 11.28 13,307 150,103 Sep 05 05:03 PM Williams David Solomon III Director Aug 29 '24 Sale 11.26 4,000 45,040 36,899 Sep 03 08:25 PM Williams David Solomon III Director May 23 '24 Sale 9.90 3,100 30,690 26,679 Sep 03 08:25 PM Williams David Solomon III Director May 24 '24 Sale 9.97 1,409 14,048 25,270 Sep 03 08:25 PM Richard A. Barasch Former Affiliate Aug 28 '24 Proposed Sale 10.79 18,034 194,587 Aug 28 04:17 PM Richard A. Barasch Former Affiliate Aug 19 '24 Proposed Sale 10.46 10,235 107,058 Aug 19 07:08 PM Richard A. Barasch Former Affiliate Aug 15 '24 Proposed Sale 10.04 25,614 257,165 Aug 15 05:00 PM Flynn James E 10% Owner Mar 11 '24 Sale 11.02 182,607 2,012,557 11,643,769 Mar 12 07:01 PM Flynn James E 10% Owner Mar 12 '24 Sale 10.70 114,906 1,229,494 11,528,863 Mar 12 07:01 PM Flynn James E 10% Owner Mar 08 '24 Sale 10.93 52,487 573,652 11,826,376 Mar 12 07:01 PM Williams David Solomon III Director Dec 04 '23 Sale 9.30 2,255 20,972 29,779 Dec 06 05:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
